This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
During 2024, we published 155 blogs , 244 reviews of scientific findings , 43 personal stories and 41 MIA reports , of which 22 were podcast interviews. Here we highlight the top ten of Mad in Americas most-read blogs and personal stories of 2024. Carly tells that Joey was on almost thirty different medications between 2015 and 2024.
The study, titled “Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey,” delves into the challenging decisions faced by individuals considering SSRI and SNRI antidepressants, which are common treatments for depression. Chevance, A., … & Salanti, G. (2024). Furukawa, T.
American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depressiontreatment,” was born of scientific misconduct.
Specifically, in 2024, internist and epidemiologist G. Psychiatric News reported in 2024 that PubMed shows more than 400 trials of ketamine as a depressiontreatment in the past decade; however, it also reports that G.
As of May, 2024, a search of TRD on Google Scholar yields 96,300 hits. It showed up in the literature for the first time in 1974, when a small number of psychiatrists published some clinical observations of a “therapy resistant depression.” The eighties and nineties were a depression-treatment renaissance.
The first NIMH treatment outcome study , which was published in 1989, found the drug treatment (imipramine) to be no more effective than placebo when measures were taken after three months of treatment. I raised this double standard, too, with Ellen Barry, and got no response.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content